
MerRaZymes outreach via Wikimedia:
In collaboration with MetRaZyme’s training and communication partner, Wikimedia, our Doctoral Candidates (DCs) received training on editing and writing Wikipedia articles. A summary of their contributions can be found here:
Selected Conference Participations/Organizations by Our Team:
European Polymer Congress 2025 (sponsored by MetRaZymes)
Professor Katja Loos (MetRaZymes PI) organized the European Polymer Congress in Groningen from June 22-27, 2025. Many of MetRaZymes’ PIs and PhD students presented their MetRaZymes projects there.



Repurposed & Artificial Enzymes Conference 2025 (sponsored by MetRaZymes)
Professor Thomas Ward (MetRaZymes PI) and his group organized a conference on Repurposed and Artificial Enzymes, RepArtZymes, in Basel from June 26-29, 2025. It included an inspiring talk by Nobel laureate Professor Frances Arnold, as well as poster and oral presentations by many of MetRaZymes’ PIs and PhD students.


Recombinant Protein Production Conference RPP12 (sponsored by MetRaZymes)
Professor Ralf Takors (MetRaZymes PI) organized the 12th Conference on Recombinant Protein Production in Ulm/Neu-Ulm from October 7-9, 2025. During the event, the MetRaZymes project was presented by both MetRaZymes’ PI and DC.

Artzymes at the Long Night of Research ( April 24th, 2026, Vienna)
The MetRaZyme team presented ‘Artzymes,’ a visual exploration of our scientific journey. Utilizing Thin Layer Chromatography (TLC) to illustrate complexity, the exhibit featured individual TLC plates—each representing a specific PhD project—that merged into a cohesive yet intricate whole, displayed alongside layered researcher portraits.

Future Events:
The European Biological Inorganic Chemistry Conference (EuroBIC), organized by Professor Gerard Roelfes (MetRaZymes PI), will be held from July 12th to July 16th, 2026, in Groningen. The event will feature a specialized MetRaZymes-themed session: “(Artificial) Metalloenzymes for Radical Biocatalysis.” Many members of our team will be there to present their latest research.

